Pacira Biosciences Inc PCRX:NASDAQ

Last Price$59.64NASDAQ Previous Close - Last Trade as of 3:59PM ET 6/18/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$59.60 (34)
Ask (Size)$59.61 (15)
Day Low / HighN/A - N/A
Volume1.3 M
  • Latest Stories
  • Commentary and Analysis
Insider Trends: Pacira Biosciences Insider Extends 90-Day Selling Trend
6:09PM ET 6/10/2021 MT Newswires

On Jun 08, 2021, Dr Donald C Manning, Chief Medical Officer, reported a sale of 2,600 shares in Pacira Biosciences (PCRX) for $158,964. Following the Form...

Insiders at Pacira Biosciences (PCRX) Make Significant Stock Sales Extends the Trend of Last Quarter
10:21PM ET 6/09/2021 MT Newswires

Nine insiders listed below, disposed of 32,948 shares of Pacira Biosciences having a market value of approximately $2,010,550, today, as disclosed in form...

Insider Trends: Insider Adds to Selling Trend at Pacira Biosciences
4:22PM ET 6/08/2021 MT Newswires

On Jun 04, 2021, Dr Roy Winston, Chief Clinical Officer, reported a sale of 2,276 shares in Pacira Biosciences (PCRX) for $138,920. Dr Winston, after the...

Insider Trends: Pacira Biosciences Insider Extends 90-Day Selling Trend
4:22PM ET 6/08/2021 MT Newswires

Kristen Marie Williams, Chief Administrative Officer, sold 3,930 shares of Pacira Biosciences (PCRX) on Jun 04, 2021, for $239,875. Subsequent to the Form...

Insider Trends: Pacira Biosciences Insider Extends 90-Day Selling Trend
4:21PM ET 6/08/2021 MT Newswires

David M Stack, Director and CEO & Chairman, sold 14,905 shares of Pacira Biosciences (PCRX) on Jun 04, 2021, for $909,756. Subsequent to the Form 4 filing...

Insider Trends: Insider Prolongs 90-Day Selling Trend at Pacira Biosciences
4:19PM ET 6/08/2021 MT Newswires

Max Reinhardt, President, Rest of World, on Jun 04, 2021, sold 3,500 shares in Pacira Biosciences (PCRX) for $212,406. Subsequent to the Form 4 filing...

Insider Trends: Insider Prolongs 90-Day Selling Trend at Pacira Biosciences
4:19PM ET 6/08/2021 MT Newswires

Charles A Reinhart III, CFO, executed a sale of 2,648 shares in Pacira Biosciences (PCRX) on Jun 04, 2021, for $161,626. Reinhart, following the...

Insider Trends: Selling By Insiders Lingers at Pacira Biosciences
4:18PM ET 6/08/2021 MT Newswires

Dennis McLoughlin, Chief Customer Officer, sold 1,895 shares in Pacira Biosciences (PCRX) for $115,665 on Jun 04, 2021. Following the Form 4 filing with...

Insider Trends: Insider Sales Continue 90-Day Trend at Pacira Biosciences
4:17PM ET 6/08/2021 MT Newswires

Charles Anthony Laranjeira, Chief Technical Officer, sold 2,117 shares in Pacira Biosciences (PCRX) on Jun 04, 2021, for $129,215. Following the Form 4...

Pacira BioSciences Reports Decline in Preliminary May Net Sales of Pain Management Products
8:51AM ET 6/08/2021 MT Newswires

Pacira BioSciences (PCRX) reported Tuesday preliminary net sales of $41.2 million for Exparel and $1 million for iovera for May. Last month, the company...